University Hospital Heidelberg – Germany
About Prof. Dr. Wolfgang Wick
Prof. Dr. med. Wolfgang Wick is the Medical Director of the Department of Neurology at Heidelberg University Hospital and Head of the Clinical Cooperation Unit Neuro-oncology at the German Cancer Research Center (DKFZ). With international training across Bonn, London, and Harvard, he is recognised as one of the best Neurology and Neuro-Oncology doctors in Germany.
- Internationally renowned expert in clinical neuro-oncology and brain tumour treatment
- Medical Director, Department of Neurology, Heidelberg University Hospital (UKHD)
- Head, Clinical Cooperation Unit Neuro-Oncology, UKHD & DKFZ (since 2007)
- 123,000+ scientific citations across his publications
- Listed on Clarivate Analytics' Highly Cited Researchers list (since 2019)
- Best Doctoral Dissertation — Medical Faculty, University of Bonn
Qualifications & Credentials
Medical Degrees
- Medical Studies — University of Bonn, Germany; King's College London, UK; Harvard Medical School, USA
- Doctorate (Dr. med.) — Institute of Neuropathology (Prof. Dr. O.D. Wiestler), University of Bonn, Germany (Best Doctoral Dissertation, Medical Faculty Bonn)
- Habilitation in Neurology — University Hospital of Tübingen, Germany
Fellowships & Special Training
- Specialist Training in Neurology — University of Tübingen (Prof. Dr. J. Dichgans)
- Research Fellowship — Department of Psychiatry, University of Tübingen (Prof. Dr. G. Buchkremer)
Certifications & Accreditations
- German Medical Council Registration
- Specialist Certification — Neurology with Subspecialty in Neuro-Oncology
- Faculty of 1000 Medicine — Member
- Member — European Association for Neuro-Oncology (EANO)
- Member — Society for Neuro-Oncology (SNO), USA
- Member — German Cancer Society (DKG)
- Member — German Society of Neurology (DGN)
Areas of Expertise
Major Conditions Treated
- Glioblastoma (GBM)
- Glioma (Astrocytoma, Oligodendroglioma — IDH-mutant and IDH-wildtype)
- CNS Lymphoma
- Brain Metastases
- Meningioma
- Medulloblastoma (Adult)
- Spinal Cord Tumours
- Paraneoplastic Neurological Syndromes
- Treatment-Resistant Brain Tumours
- Neuro-Oncological Complications of Cancer
Sub-specialties
- Clinical Neuro-Oncology & Glioblastoma: Internationally recognised authority on glioblastoma treatment, glioma biology, and translational neuro-oncology — a leading Neurology specialist in Heidelberg, Germany.
- Translational Brain Tumour Research: Head of the DKFZ Clinical Cooperation Unit Neuro-Oncology — recognised among the best Neurology / Neuro-Oncology doctors in Germany.
- Personalised & Immunotherapy in Brain Tumours: Specialist in molecular-targeted therapy, vaccination strategies, and tumour-treating fields (TTFields).
Advanced Procedures & Treatments
- Personalised Chemotherapy for Glioblastoma (Temozolomide-based protocols)
- MGMT-Methylation Stratified Treatment
- Tumour-Treating Fields (TTFields)
- Targeted Molecular Therapy for Glioma
- Immunotherapy & Vaccination Trials in Brain Tumours
- Treatment of CNS Lymphoma (High-Dose Methotrexate Protocols)
- Brain Metastasis Management
- Clinical Trials of Investigational Neuro-Oncology Drugs
- Multidisciplinary Tumour Board Coordination
- Cerebrospinal Fluid (CSF) Diagnostics
Professional Experience
Current Affiliation
- Heidelberg University Hospital (UKHD), Heidelberg, Germany — Medical Director, Department of Neurology & Polyclinic; Managing Director of the Neurological Clinic; Spokesman for the Head Clinic Center, since 2014 (Present)
- National Center for Tumor Diseases (NCT), Heidelberg, Germany — Medical Director, Department of Neuro-Oncology, since 2007 (Present)
- German Cancer Research Center (DKFZ), Heidelberg, Germany — Head, Clinical Cooperation Unit Neuro-Oncology, since 2007 (Present)
Past Affiliations
- University Hospital of Tübingen, Germany — Deputy Medical Director, Department of General Neurology
- University of Tübingen, Germany — AiP (Trainee), Department of Neurology (Prof. Dr. J. Dichgans)
- University of Tübingen, Germany — Research Associate, Department of Psychiatry
- University of Bonn, Germany — Doctoral Researcher, Institute of Neuropathology
Academic & Research Roles
- Member — Faculty of 1000 Medicine
- Senior Faculty — German Cancer Society and European Association for Neuro-Oncology (EANO)
- Listed on Clarivate Analytics' Highly Cited Researchers list (since 2019)
- Highly cited author in neuro-oncology with 123,000+ citations
Key Achievements
- Listed on Clarivate Analytics' Highly Cited Researchers list — annually since 2019
- 123,000+ academic citations across his publications
- Best Doctoral Dissertation — Medical Faculty, University of Bonn
- Key Note Lecturer — World Federation of Neuro-Oncology Meeting, Japan
- Member — Faculty of 1000 Medicine
- Founder of Heidelberg's clinical neuro-oncology programme
Awards & Recognitions
National & International Awards
- Best Doctoral Dissertation — Medical Faculty, University of Bonn
- Clarivate Analytics Highly Cited Researchers — annually since 2019
- Key Note Lecturer — World Federation of Neuro-Oncology Meeting, Japan
Professional Memberships
- European Association for Neuro-Oncology (EANO)
- Society for Neuro-Oncology (SNO), USA
- German Cancer Society (DKG)
- German Society of Neurology (DGN)
- Faculty of 1000 Medicine
Research & Publications
Published Papers (Selected)
- Wick W, Weller M, et al. "Understanding and Treating Glioblastoma." Neurol Clin. 2018;36(3):485–499.
- EORTC 26082 — Lead Investigator: Radiation therapy and concurrent plus adjuvant Temsirolimus (CCI-779)/RT versus chemoirradiation with temozolomide in newly diagnosed MGMT-unmethylated glioblastoma — randomised multicenter Phase II study.
- Multiple peer-reviewed publications on glioma immunotherapy, IDH-mutant glioma management, COVID-19 impact on neuro-oncology, and net clinical benefit calculations in neuro-oncology trials. Citation list available via PubMed and Heidelberg University.
Ongoing Research & Clinical Interests
- Glioblastoma treatment resistance mechanisms
- CNS lymphoma — diagnosis and therapy
- Tumour microenvironment and stem cells in glioma
- Immunotherapy and vaccination strategies in brain tumours
- Health-related quality of life in neuro-oncology trials
- Translational bench-to-bedside research
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (EUR) | Estimated Cost (USD) |
|---|---|---|
| Neuro-Oncology Consultation | €300 – €600 | $325 – $650 |
| Comprehensive Brain Tumour Workup (MRI + Molecular) | €3,500 – €7,000 | $3,800 – $7,560 |
| Glioblastoma Standard-of-Care Therapy (Stupp Protocol) | €25,000 – €50,000 | $27,000 – $54,000 |
| Tumour-Treating Fields (TTFields, per month) | €18,000 – €25,000 | $19,500 – $27,000 |
| Targeted Therapy (per cycle, drug-dependent) | €5,000 – €15,000 | $5,400 – $16,200 |
| CNS Lymphoma High-Dose Methotrexate Protocol | €20,000 – €40,000 | $21,500 – $43,000 |
| Second Opinion via Telemedicine | €400 – €700 | $430 – $755 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. med. Wolfgang Wick use in Neurology and Neuro-Oncology treatment?
Prof. Dr. med. Wolfgang Wick employs the latest evidence-based tools and minimally invasive techniques relevant to Neurology and Neuro-Oncology. Virtual consultations and remote second opinions are also available to international patients. Contact Cancer Rounds for a detailed technology overview specific to your case.
2. What conditions does Prof. Dr. med. Wolfgang Wick specialize in treating?
Prof. Dr. med. Wolfgang Wick is a specialist in Neurology and Neuro-Oncology, treating a broad spectrum of conditions in this field — including both common presentations and complex, rare cases. International patients seek treatment for conditions requiring expert Neurology and Neuro-Oncology care in Heidelberg, Germany.
3. How do I book an appointment with Prof. Dr. med. Wolfgang Wick?
Appointments with Prof. Dr. med. Wolfgang Wick can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. med. Wolfgang Wick?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. med. Wolfgang Wick, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. Dr. med. Wolfgang Wick offer second opinions for Neurology and Neuro-Oncology cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Neurology and Neuro-Oncology specialist in Heidelberg, Germany.
